Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 4 | 2022 | 153 | 0.500 |
Why?
|
| Macrophages | 4 | 2022 | 1039 | 0.290 |
Why?
|
| Monocytes | 3 | 2022 | 353 | 0.290 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2017 | 98 | 0.260 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 208 | 0.250 |
Why?
|
| Ichthyosis | 1 | 2024 | 8 | 0.220 |
Why?
|
| Glutaredoxins | 2 | 2022 | 2 | 0.220 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 46 | 0.200 |
Why?
|
| Fresh Water | 1 | 2022 | 12 | 0.190 |
Why?
|
| Microbiota | 1 | 2024 | 129 | 0.190 |
Why?
|
| Fishes | 1 | 2022 | 21 | 0.190 |
Why?
|
| Protective Agents | 1 | 2022 | 12 | 0.190 |
Why?
|
| Comparative Effectiveness Research | 1 | 2012 | 49 | 0.180 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 31 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 198 | 0.160 |
Why?
|
| Women | 1 | 2019 | 44 | 0.150 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 76 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 65 | 0.150 |
Why?
|
| Deoxyglucose | 1 | 2017 | 32 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 33 | 0.140 |
Why?
|
| Oxidative Stress | 2 | 2022 | 298 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2019 | 289 | 0.130 |
Why?
|
| Glutamine | 1 | 2017 | 47 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 32 | 0.130 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2016 | 4 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 73 | 0.130 |
Why?
|
| Glucose | 2 | 2016 | 467 | 0.130 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 348 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 175 | 0.120 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2012 | 701 | 0.110 |
Why?
|
| Inflammation | 2 | 2024 | 1148 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 762 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 62 | 0.110 |
Why?
|
| Obesity | 1 | 2022 | 1234 | 0.110 |
Why?
|
| HIV Infections | 1 | 2019 | 969 | 0.090 |
Why?
|
| Vietnam | 2 | 2022 | 173 | 0.080 |
Why?
|
| Oxidation-Reduction | 2 | 2022 | 326 | 0.070 |
Why?
|
| Mice | 5 | 2022 | 10844 | 0.070 |
Why?
|
| Aorta | 2 | 2017 | 114 | 0.060 |
Why?
|
| Animals | 6 | 2022 | 20661 | 0.060 |
Why?
|
| Receptors, LDL | 2 | 2016 | 34 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 242 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2157 | 0.050 |
Why?
|
| Phenotype | 2 | 2016 | 1207 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2021 | 11 | 0.040 |
Why?
|
| Boron Compounds | 1 | 2021 | 20 | 0.040 |
Why?
|
| Glycine | 1 | 2021 | 49 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 56 | 0.040 |
Why?
|
| Granulocytes | 1 | 2021 | 71 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1122 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 224 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2021 | 132 | 0.040 |
Why?
|
| Transcriptome | 1 | 2022 | 388 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2186 | 0.040 |
Why?
|
| Autoradiography | 1 | 2017 | 53 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 777 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1469 | 0.030 |
Why?
|
| Humans | 5 | 2024 | 63466 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 202 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 189 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2014 | 3 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 3396 | 0.030 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2014 | 4 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 58 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 41 | 0.030 |
Why?
|
| Female | 3 | 2022 | 32886 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 145 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2576 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 694 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 2337 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 622 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 936 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2679 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1353 | 0.020 |
Why?
|
| Child | 1 | 2019 | 4535 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4695 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2109 | 0.020 |
Why?
|
| United States | 1 | 2012 | 7845 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6252 | 0.020 |
Why?
|
| Male | 2 | 2022 | 29904 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3770 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2609 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 16828 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 17605 | 0.010 |
Why?
|